Silencing of TGM2 Reverses Epithelial to Mesenchymal Transition and Modulates the Chemosensitivity of Breast Cancer to Docetaxel

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2015.2679
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells

Viruses
VirologyInfectious Diseases
2015English

Loss of CLCA4 Promotes Epithelial-To-Mesenchymal Transition in Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Anxa2 Binds to STAT3 and Promotes Epithelial to Mesenchymal Transition in Breast Cancer Cells

Oncotarget
Oncology
2015English

Silibinin Attenuates Radiation-Induced Intestinal Fibrosis and Reverses Epithelial-To-Mesenchymal Transition

Oncotarget
Oncology
2017English

cFLIP Critically Modulates Apoptotic Resistance in Epithelial-To-Mesenchymal Transition

Oncotarget
Oncology
2017English

LincRNA-ROR Induces Epithelial-To-Mesenchymal Transition and Contributes to Breast Cancer Tumorigenesis and Metastasis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Epithelial-Mesenchymal Transition—A Hallmark of Breast Cancer Metastasis

Cancer Hallmarks
2013English

Zoledronic Acid Reverses the Epithelial-Mesenchymal Transition and Inhibits Self-Renewal of Breast Cancer Cells Through Inactivation of NF- B

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Function of GCN5 in the TGF‑β1‑induced Epithelial‑to‑mesenchymal Transition in Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy